Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-23-000595
Filing Date
2023-05-02
Accepted
2023-05-02 08:53:02
Documents
49
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pktx_10q.htm   iXBRL 10-Q 486957
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 11504
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 11396
4 EXHIBIT 32 ex32.htm EX-32 6518
  Complete submission text file 0001079973-23-000595.txt   2695156

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pktx-20230331.xsd EX-101.SCH 25108
6 XBRL CALCULATION FILE pktx-20230331_cal.xml EX-101.CAL 24992
7 XBRL DEFINITION FILE pktx-20230331_def.xml EX-101.DEF 92890
8 XBRL LABEL FILE pktx-20230331_lab.xml EX-101.LAB 185969
9 XBRL PRESENTATION FILE pktx-20230331_pre.xml EX-101.PRE 159854
43 EXTRACTED XBRL INSTANCE DOCUMENT pktx_10q_htm.xml XML 368211
Mailing Address 109 W. MAIN ST. DALTON OH 44618
Business Address 109 W. MAIN ST. DALTON OH 44618 330-445-4971
ProtoKinetix, Inc. (Filer) CIK: 0001128189 (see all company filings)

EIN.: 943355026 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32917 | Film No.: 23876810
SIC: 2834 Pharmaceutical Preparations